PharmaShots | Incisive News in 3 Shots

Subscribe Now

Kura Oncology

Kura Oncology Reports First Patient Dosing of Ziftomenib in P-II (KOMET-001) Registration-Directed Trial for NPM1-Mutant Acute Myeloid Leukemia

Kura Oncology Reports First Patient Dosing of Ziftomenib in P-II (KOMET-001) Registration-Directed Trial for NPM1-Mutant Acute Mye...

February 10, 2023

Kura Oncology Reports the US FDA's Clinical Hold on the P-Ib Study of KO-539 for the Treatment of Acute Myeloid Leukemia

Kura Oncology Reports the US FDA's Clinical Hold on the P-Ib Study of KO-539 for the Treatment of Acute Myeloid Leukemia

November 25, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us